Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
05/2009
05/06/2009CN101426796A Meridamycin analogues for the treatment of neurodegenerativedisorders
05/06/2009CN101426486A Compounds for the treatment of inflammatory disorders and microbial diseases
05/06/2009CN101423518A Imidazole derivates and medical use thereof
05/06/2009CN100484941C Compound forming heterocyclic azo dye and method for making dye
05/05/2009US7528160 {6-[5-Methyl-2-(4-trifluoromethyl-phenyl)-oxazol-4-ylmethoxy]-benzo[b]thiophen-3-yl}-acetic acid; antidiabetic agent; metabolic Syndrome, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; lowering fibrinogen, increasing HDL levels
05/05/2009US7528148 Pyrazolo[3,4-B]pyridine compounds, and their use as phosphodiesterase inhibitors
05/05/2009US7528147 e.g. 2 {5,6-dimethoxy-1-[2-(4-methylpiperazin- 1 -yl)ethyl]-1H-indol-3 -yl}-1H-pyrrolo[2,3- b]pyridine; Insulin Growth Factor-1 (somatomedin) antagonist; antiproliferative, antitumor agent; solid tumor; prostate, lung and breast cancer
05/05/2009CA2513549C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
05/05/2009CA2149298C Flk-1 is a receptor for vascular endothelial growth factor
04/2009
04/30/2009WO2009055331A2 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119
04/30/2009WO2009053716A1 Purine derivatives useful as pi3 kinase inhibitors
04/30/2009WO2009023126A3 Bicyclic amides for enhancing glutamatergic synaptic responses
04/30/2009WO2008140421A3 Heterocycloalkyl substituted pyrimidine derivatives
04/30/2009WO2008140420A3 Pyrimidine derivatives
04/30/2009WO2008140419A3 Pyridyl substituted pyrimidine derivatives
04/30/2009US20090111985 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
04/30/2009US20090111820 Fused pyrrolidine 1,2,4-triazole derivatives as modulators of mglur5
04/30/2009US20090111151 Production of Polyketides
04/30/2009CA2703203A1 Bicyclic heterocycle derivatives and methods of use thereof
04/30/2009CA2703138A1 Purine derivatives useful as pi3 kinase inhibitors
04/30/2009CA2699933A1 Fungicidal mixtures
04/29/2009EP2051984A1 Crystalline forms of rapamycin analogs
04/29/2009EP1537123B1 Amino-substituted cyclohexane derivatives for the treatment of bacterial infections
04/29/2009EP1446125B1 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
04/29/2009EP1438288B1 Substituted thioacetamides
04/29/2009CN101421280A Substituted-dihydro[1,4]oxazino[2,3,4-hi]indazole derivatives as 5-hydroxytryptamine-6 ligands
04/29/2009CN101421279A Imidazo compounds
04/29/2009CN101421278A Condensed imidazole derivatives as aldosterone synthase inhibitors
04/29/2009CN101421277A Imidazo compounds
04/29/2009CN101418003A 5-aryl-9-alkyl-4,6-dioxo-1-aza-bicyclo[3.3.1]nonane hydrochloride and preparation method thereof
04/29/2009CN100482668C Method for the manufacture of thip
04/29/2009CN100482666C Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics
04/29/2009CN100482225C Novel heterocyclic compounds which are active as inhibitors of beta-lactamases
04/28/2009US7524969 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics
04/28/2009US7524953 Coloring macromolecular material such as plastics, coatings, paints, electrophotography toners and developers, color filter and printing inks
04/28/2009US7524864 Methods of treating sleep disorders
04/28/2009US7524862 Melanin-concentrating hormone (MCH); for the treatment of metabolic disorders and/or eating disorders, such as obesity and diabetes, also drug dependencies, and urinary incontinence
04/28/2009US7524860 Antibacterial agents
04/28/2009US7524843 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics
04/28/2009CA2380074C Novel amide derivatives
04/28/2009CA2346396C 4,5-dihydro-isoxazole derivatives and their pharmaceutical use
04/28/2009CA2164838C A lotion comprising a tricyclic macrolide
04/23/2009WO2009051820A2 Use of oxazine compounds for making chromogenic materials
04/23/2009WO2009051162A1 Method for producing bicyclo ring compound
04/23/2009WO2009050237A1 Cgrp antagonists
04/23/2009WO2009050234A1 Cgrp antagonists
04/23/2009WO2009049525A1 Oxazinocamptothecin derivatives and their preparation and use
04/23/2009WO2008068569A3 Processes for the preparation of clopidogrel hydrochloride
04/23/2009US20090105294 Biosynthetic Gene Cluster for the Production of a Complex Polyketide
04/23/2009US20090105290 Substituted 1-oxa-3,8-diazaspiro[4.5]-decan-2-one-Compounds and the Use Thereof for Producing Drugs
04/23/2009US20090105229 Purine derivatives as kinase inhibitors
04/23/2009US20090105227 Thienopyrroles As Antiviral Agents
04/23/2009CA2702503A1 Cgrp-antagonists
04/22/2009EP2049520A2 Indole compounds
04/22/2009EP2049491A1 Heteroaryl compounds useful as inhibitors of e1 activating enzymes
04/22/2009EP1387842B1 Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors
04/22/2009CN101415716A Condensed imidazole derivatives as aldosterone synthase inhibitors
04/22/2009CN101415710A Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators
04/22/2009CN101415706A Azolopyridin-3-one derivatives as inhibitors of endothelial lipase
04/22/2009CN101415701A Heterocyclylacrylamide compounds as FABI inhibitors and antibacterial agents
04/22/2009CN101415419A Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators
04/22/2009CN100480245C 2-amino-4H-3.1-benzoxazinone-4-keto derivatives for treatment of obesity
04/21/2009US7521475 Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof
04/21/2009US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
04/21/2009CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
04/16/2009WO2009046841A2 Piperidine and piperazine derivatives for treating tumours
04/16/2009WO2008054674A3 Antidiabetic bicyclic compounds
04/16/2009US20090099162 Novel Oxabispidine Compounds And Their Use In The Treatment Of Cardiac Arrhythmias
04/16/2009CA2701519A1 Piperidine and piperazine derivatives
04/15/2009EP1719773B1 Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor
04/15/2009CN101410402A Buprenorphine derivatives and uses thereof
04/15/2009CN101407524A Oxazino camptothecin derivative, preparation and use thereof
04/15/2009CN101406471A Novel heterocyclic compounds which are active as inhibitors of beta-lactamases
04/14/2009US7517925 Adjust adhesion at interface of microelectronics packages; shrinkage inhibition
04/14/2009US7517895 Synthetic diazonamides
04/14/2009CA2232378C Aerosol compositions
04/09/2009WO2009044788A1 Benzoxazinone derivative
04/09/2009WO2009010694A3 Dyeing method using a styryl- or imine-type disulfide/thiol compound and stimuli, composition and device for implementing same
04/09/2009WO2009003595A3 Macrolactone derivatives
04/09/2009US20090093640 Synthesis of enone intermediate
04/09/2009US20090093478 N-aroyl cyclic amines
04/09/2009CA2701406A1 Benzoxazinone derivative
04/08/2009EP2044084A2 Mtki quinazoline derivatives
04/08/2009EP2044077A1 Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
04/08/2009EP1565475B1 Diazinopyrimidines and their use as protein kinase inhibitors
04/07/2009US7514567 Oxazolidinone nicotinic acetylcholine receptor agonists
04/07/2009US7514554 One step; chlorination
04/07/2009US7514448 Azaindoles useful as inhibitors of rock and other protein kinases
04/07/2009US7514427 Aids therapy; viricides
04/07/2009CA2377147C New indolocarbazole alkaloids from a marine actinomycete
04/07/2009CA2256633C Selected derivatives of k-252a
04/02/2009WO2009040817A2 Salarins and tulearins, compositions and uses thereof
04/02/2009WO2009006243A3 Processes for preparing bicyclic oxazine carboxaldehyde and beta-lactamase inhibitors
04/02/2009US20090088425 Glucocorticoid receptor antagonists
04/02/2009US20090088423 Methods and compositions for treating bacterial infections and diseases associated therewith
04/02/2009US20090088414 Soluble 17-amino-analogs of geldanamycin in acid addition salt form; water solubility; anticancer agents; storage stability
04/02/2009US20090088406 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
04/02/2009US20090087865 Monoclonal Antibodies to Tacrolimus and Immunoassays Methods for Tacrolimus
04/02/2009US20090087409 Viral Polymerase Inhibitors
04/01/2009EP2042505A1 Polymorphic forms of a GABAa agonist
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 220